MedKoo Cat#: 574144 | Name: Imidocarb propionate
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Imidocarb propionate is an antiprotozoal agent that eliminates blood parasites. Formulations containing imidocarb have been used in the veterinary treatment of babesiosis and other protozoal infections.

Chemical Structure

Imidocarb propionate
Imidocarb propionate
CAS#55750-06-6 (propionate)

Theoretical Analysis

MedKoo Cat#: 574144

Name: Imidocarb propionate

CAS#: 55750-06-6 (propionate)

Chemical Formula: C25H32N6O5

Exact Mass:

Molecular Weight: 496.57

Elemental Analysis: C, 60.47; H, 6.50; N, 16.92; O, 16.11

Price and Availability

Size Price Availability Quantity
1g USD 250.00 2 Weeks
5g USD 550.00 2 Weeks
10g USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Imidocarb propionate
IUPAC/Chemical Name
N,N'-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea, dipropanoate
InChi Key
AFGQXWSHYUHHNV-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H20N6O.2C3H6O2/c26-19(24-15-5-1-3-13(11-15)17-20-7-8-21-17)25-16-6-2-4-14(12-16)18-22-9-10-23-18;2*1-2-3(4)5/h1-6,11-12H,7-10H2,(H,20,21)(H,22,23)(H2,24,25,26);2*2H2,1H3,(H,4,5)
SMILES Code
O=C(NC1=CC=CC(C2=NCCN2)=C1)NC3=CC(C4=NCCN4)=CC=C3.OC(CC)=O.OC(CC)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Imidocarb dipropionate is a potent antiprotozoal agent. Imidocarb dipropionate is active against the parasite B. bovis with an IC50 of 87 μg/mL.
In vitro activity:
TBD
In vivo activity:
These findings establish that imidocarb dipropionate treatment clears B. caballi infection with confirmation of lack of transmission risk either by direct blood transfer or a high tick burden. Reference: Antimicrob Agents Chemother. 2009 Oct;53(10):4327-32. https://pubmed.ncbi.nlm.nih.gov/19620328/
Solvent mg/mL mM
Solubility
DMF 1.0 2.01
DMSO 16.8 33.85
Ethanol 1.0 2.01
PBS (pH 7.2) 10.0 20.14
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 496.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Schwint ON, Ueti MW, Palmer GH, Kappmeyer LS, Hines MT, Cordes RT, Knowles DP, Scoles GA. Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential. Antimicrob Agents Chemother. 2009 Oct;53(10):4327-32. doi: 10.1128/AAC.00404-09. Epub 2009 Jul 20. PMID: 19620328; PMCID: PMC2764191.
In vitro protocol:
TBD
In vivo protocol:
1. Schwint ON, Ueti MW, Palmer GH, Kappmeyer LS, Hines MT, Cordes RT, Knowles DP, Scoles GA. Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential. Antimicrob Agents Chemother. 2009 Oct;53(10):4327-32. doi: 10.1128/AAC.00404-09. Epub 2009 Jul 20. PMID: 19620328; PMCID: PMC2764191.
1. Mosqueda, J., Olvera-Ramírez, A., Aguilar-Tipacamú, G., et al. Current advances in detection and treatment of babesiosis. Curr. Med. Chem. 19(10), 1504-1518 (2012). 2. Rodriguez, R.I., and Trees, A.J. In vitro responsiveness of Babesia bovis to imidocarb dipropionate and the selection of a drug-adapted line. Vet. Parasitol. 62(1-2), 35-41 (1996). 3. Sevinc, F., Turgut, K., Sevinc, M., et al. Therapeutic and prophylactic efficacy of imidocarb dipropionate on experimental Babesia ovis infection of lambs. Vet. Parasitol. 149(1-2), 65-71 (2007).